NYU Managing Epilepsy Well (MEW) Study: A Randomized Controlled Trial of Telephone-Based Support for People With Epilepsy

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a two-arm randomized controlled trial to compare telephone-based depression self-management (UPLIFT) to telephone-based support groups (BOOST). A sample of 120 English- and Spanish-speaking people with epilepsy (PWE) with elevated depressive symptoms will be enrolled. Both interventions are 8-week programs delivered in one-hour weekly sessions to groups of about 6 participants. Changes in depressive symptoms, quality of life and seizures will be assessed over 12 months. The trial will also examine mediators and moderators of treatment effects.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:

• adult (≥18 years of age);

• diagnosed with epilepsy for at least one year;

• fluent in English or Spanish;

• elevated depressive symptoms (PHQ-9 score ≥10);

• willing to participate in audiotaped group telephone sessions

Locations
United States
New York
NYU Langone Health
RECRUITING
New York
Contact Information
Primary
Tanya Spruill, PhD
Tanya.Spruill@nyulangone.org
646-501-3429
Backup
Laura Diaz, MPH
Laura.Diaz@nyulangone.org
Time Frame
Start Date: 2021-11-09
Estimated Completion Date: 2026-08-31
Participants
Target number of participants: 120
Treatments
Experimental: Arm 1: UPLIFT (Using Practice and Learning to Increase Favorable Thoughts)
UPLIFT is a telephone-based depression self-management program for people with epilepsy.
Active_comparator: Arm 2: BOOST (Bringing Out Our Strength Together)
BOOST is a telephone-based support program for people with epilepsy.
Related Therapeutic Areas
Sponsors
Leads: NYU Langone Health

This content was sourced from clinicaltrials.gov